AstraZeneca US News and Activities

AstraZeneca US is owned by AstraZeneca.

AstraZeneca is one of the...

• Forbes Global 2000 (#109);
• Fortune 500 Europe (#87);
• FTSE 350;
• Nasdaq 100;
• Stoxx 600;
• TOB Iconic 10,000.

AstraZeneca is a company listed under the stock ticker AZN (GB).

AstraZeneca has a direct presence in 31 countries.

AstraZeneca has 47 subsidiaries including Alexion Pharma Europe, Alexion Pharma France and Alexion Pharma Ireland.

They are in:

• Pharmaceuticals85%
• Biotechnology13%
• Other2%

Acquisition, funding and merger involving AstraZeneca.

• AstraZeneca has acquired Fusion Pharma (posted on June 6 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• AstraZeneca has acquired Gracell Biotechnologies (posted on February 23 2024).
• See more news about AstraZeneca Hide news involving AstraZeneca

View the org chart displaying its 56 main executives

Most searched biographies at AstraZeneca US

• Joris Silon, Country President, BioPharmaceuticals Business Unit
• Monica Marsh, Vice President, Human Resources, Commercial
• William Mongan, Vice President, Business Development, New Product ...

Popular executive movements at AstraZeneca

• Alan Harrison, who was Global Senior Director, Talent, is promoted to Global Head,Talent and Talent Scouting  (posted on April 28 2025).
• Karen Knudsen will join the company as Non-Executive Director on Apr. 11, 2025  (posted on February 18 2025).
• Rene Haas will join the company as Non-Executive Director on Jan. 1, 2025  (posted on December 16 2024).

Click here to view some more movements at AstraZeneca

Create your alert
to follow the executive moves at AstraZeneca US.

AstraZeneca has 1,837 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• ESSA Pharma and Xoma have announced they will merge  (posted on July 14 2025)..
• Pathos becomes a unicorn with its fundraising of $365 Million. (posted on July 4 2025).
• Vor Biopharma and Incyte have announced they will merge  (posted on June 30 2025)..

Popular contacts in Pharmaceuticals

• Linh Kha - Senior Vice President and General Manager, Japan Asia-Pacific at Amgen
• Seth Harrison - Chairman and Director at Braeburn Pharmaceuticals
• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets at Bristol-Myers Squibb

Learn more about the Pharmaceuticals industry

Press releases by AstraZeneca US

• Press Releases
• Press Releases
• Our update on COVID-19
• Press Releases

Social media about AstraZeneca US

• AstraZeneca US on Wikipedia, Google News & Yahoo Finance
• AstraZeneca US on LinkedIn, Twitter & YouTube